Literature DB >> 18055975

Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency.

K Matsubara1, K Imai, S Okada, M Miki, N Ishikawa, M Tsumura, T Kato, O Ohara, S Nonoyama, M Kobayashi.   

Abstract

HAX1 deficiency has recently been identified as a cause of severe congenital neutropenia (SCN), but little is known about the phenotype. We described an SCN patient with a homozygous 256C-to-T transition causing an R86X mutation in the HAX1 gene. Notably, the patient has been complicated by epilepsy and severe delay of motor, cognitive, and intellectual development; each developmental quotient was 21-26 at 7 years old. Growth failure and dental development delay were also noted. Neurodevelopmental delay in this patient expands the clinical phenotype of HAX1 deficiency and suggests an important role of HAX1 on neural development as well as myelopoiesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055975     DOI: 10.3324/haematol.11973

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  9 in total

1.  Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis.

Authors:  Tatsuya Morishima; Ken-ichiro Watanabe; Akira Niwa; Hideyo Hirai; Satoshi Saida; Takayuki Tanaka; Itaru Kato; Katsutsugu Umeda; Hidefumi Hiramatsu; Megumu K Saito; Kousaku Matsubara; Souichi Adachi; Masao Kobayashi; Tatsutoshi Nakahata; Toshio Heike
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

Review 2.  Severe congenital neutropenias.

Authors:  Julia Skokowa; David C Dale; Ivo P Touw; Cornelia Zeidler; Karl Welte
Journal:  Nat Rev Dis Primers       Date:  2017-06-08       Impact factor: 52.329

3.  A novel compound heterozygous HAX1 mutation in a Chinese patient with severe congenital neutropenia and chronic myelomonocytic leukemia transformation but without neurodevelopmental abnormalities.

Authors:  Sheng-Li Xue; Jin-Li Li; Jing-Ying Zou; Jian Su; Su-Ning Chen; De-Pei Wu
Journal:  Haematologica       Date:  2011-11-18       Impact factor: 9.941

4.  HAX1 mutations causing severe congenital neuropenia and neurological disease lead to cerebral microstructural abnormalities documented by quantitative MRI.

Authors:  Kaan Boztug; Xiao-Qi Ding; Hans Hartmann; Lena Ziesenitz; Alejandro A Schäffer; Jana Diestelhorst; Dietmar Pfeifer; Giridharan Appaswamy; Sonja Kehbel; Thorsten Simon; Abdullah Al Jefri; Heinrich Lanfermann; Christoph Klein
Journal:  Am J Med Genet A       Date:  2010-12       Impact factor: 2.802

Review 5.  Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).

Authors:  Christoph Klein
Journal:  J Clin Immunol       Date:  2016-12-10       Impact factor: 8.317

Review 6.  Genetic insights into congenital neutropenia.

Authors:  Christoph Klein; Karl Welte
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

Review 7.  The role of SERCA2a/PLN complex, Ca(2+) homeostasis, and anti-apoptotic proteins in determining cell fate.

Authors:  Elizabeth Vafiadaki; Vasiliki Papalouka; Demetrios A Arvanitis; Evangelia G Kranias; Despina Sanoudou
Journal:  Pflugers Arch       Date:  2008-04-16       Impact factor: 3.657

8.  Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services.

Authors:  Jennifer L Roberts; Karine Hovanes; Majed Dasouki; Ann M Manzardo; Merlin G Butler
Journal:  Gene       Date:  2013-11-02       Impact factor: 3.688

9.  History of primary immunodeficiency diseases in iran.

Authors:  Asghar Aghamohammadi; Mostafa Moin; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2010-03       Impact factor: 0.364

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.